FDA Quality Systems Guidance Suggests "Trending" For Batch Testing
This article was originally published in The Pink Sheet Daily
Executive Summary
Monitoring for trends allows for detection of potential problems "as early as possible," FDA says. The draft guidance, released as part of FDA's GMP initiative, organizes the quality systems model into four components: management responsibilities, resources, manufacturing operations and evaluation activities.